Alaska Chapter of the American College of Cardiology

Latest in Cardiology from ACC.org

• DANCAVAS: Severe Aortic, Iliac Calcification Associated With Higher Risk of Aortic Events, MALEs
  Severe aortic and iliac calcification was associated with a significantly higher risk of major adverse limb events (MALEs) and aortic events, according to a prospective cohort study from the DANCAVAS trials published March 2 in Circulation. These results suggest that quantifying aortic calcification may provide valuable prognostic information and improve the risk stratification in patients […]
• JACC State-of-the-Art Review Highlights Growing Need For dLVAD-Related Emergency Response Resources
  With the population of stage D heart failure (HF) patients supported with durable left ventricular assist devices (dLVAD) rapidly expanding, a State-of-the-Art Review published in JACC provides a comprehensive overview of support and management of dLVAD-related emergencies, with an intent to provide a rapid-response guide for clinicians who encounter emergencies in patients with dLVADs.
• 4 Ways ACC State Chapters Are Advancing Access to Care, Strengthening the CV Workforce
  ACC State Chapters across the country have been hard at work in recent weeks advancing policies that expand access to life-saving cardiovascular care and support the health care workforce.
• AI-Enabled Clinician: Heart Failure Prediction Using AI-Enabled ECG
  In this episode, ACC Chief Innovation Officer Dr. Ami Bhatt and Dr. Akshay Desai analyze how AI-enabled electrocardiogram (ECG) can improve the prediction of heart failure.
• Management of Checkpoint Inhibitor Myocarditis in the CCU
  A 75-year-old man with a history of remote anterior ST-segment elevation myocardial infarction and stage IV malignant melanoma treated with combination immunotherapy (ipilimumab/nivolumab) presented to the oncology clinic with 3 days of exertional dyspnea and 24 hours of diplopia and neck weakness.